Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 434 entries
View as:

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

Phase: N/A Priority: Normal
NCT ID: NCT00450450 Org: User:
Start: 12/31/07 End: 03/31/22 Due: 03/31/23

Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01150669 Org: User:
Start: 07/31/10 End: 05/31/16 Due: 05/31/17

Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00004010 Org: User:
Start: 10/31/99 End: 06/30/08 Due: 06/30/09

Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States

Phase: N/A Priority: Normal
NCT ID: NCT04928599 Org: User:
Start: 03/14/22 End: 03/31/28 Due: 03/31/29

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Phase: N/A Priority: Normal
NCT ID: NCT06647953 Org: User:
Start: 03/21/25 End: 03/31/29 Due: 03/31/30

Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00671034 Org: User:
Start: 07/21/08 End: 03/31/21 Due: 03/31/22

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Phase: N/A Priority: Normal
NCT ID: NCT06894979 Org: User:
Start: 02/01/26 End: 03/31/28 Due: 03/31/29

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04994132 Org: User:
Start: 09/14/21 End: 09/30/27 Due: 09/30/28

Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01572467 Org: User:
Start: 04/30/12 End: - Due: -

Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00022126 Org: User:
Start: 11/30/02 End: 04/30/06 Due: 04/30/07

Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00053352 Org: User:
Start: 11/03/03 End: 06/30/21 Due: 06/30/22

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00369317 Org: User:
Start: 03/31/07 End: 12/31/21 Due: 12/31/22

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05602194 Org: User:
Start: 08/24/23 End: 12/30/28 Due: 12/30/29

Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00021242 Org: User:
Start: 08/31/02 End: 09/30/06 Due: 09/30/07

Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00003793 Org: User:
Start: 12/31/98 End: 03/31/07 Due: 03/31/08

Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00002875 Org: User:
Start: 12/31/96 End: 01/31/11 Due: 01/31/12

Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)

Phase: N/A Priority: Normal
NCT ID: NCT04100408 Org: User:
Start: 06/01/20 End: 09/30/25 Due: 09/30/26

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00005596 Org: User:
Start: 04/30/00 End: 07/31/07 Due: 07/31/08

Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01602666 Org: User:
Start: 06/27/12 End: 09/30/24 Due: 09/30/25

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05304585 Org: User:
Start: 08/04/22 End: 06/30/30 Due: 06/30/31

Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00002756 Org: User:
Start: 06/30/96 End: 03/31/12 Due: 03/31/13

Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT03296371 Org: User:
Start: 10/23/17 End: 12/31/25 Due: 12/31/26

Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00003573 Org: User:
Start: 11/30/98 End: 03/31/08 Due: 03/31/09

Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00553202 Org: User:
Start: 01/31/08 End: 03/31/20 Due: 03/31/21

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00567567 Org: User:
Start: 11/05/07 End: 03/31/22 Due: 03/31/23